Switzerland· 66132002

Glyxambi

A linagliptin and empagliflozin product containing empagliflozinum, linagliptinum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BD19

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedGlyxambiATCA10BD19REGISTER NO.66132002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Linagliptin and empagliflozin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD19 (linagliptin and empagliflozin), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Linagliptin and empagliflozin · ATC A10BD19

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
empagliflozinum, linagliptinum
Manufacturer
—
Country
Switzerland (CH)
ATC code
A10BD19
ATC class
Linagliptin and empagliflozin
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680661320025
    Blist 90 Stk
    CHF 252.3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a49939f0-2294-44e7-9a1b-259c75521f6d
GET /v1/drugs/a49939f0-2294-44e7-9a1b-259c75521f6d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "empagliflozinum 10 mg + linagliptinum 5 mg",
  "valid_from": "2018-03-01",
  "limitations": "[{\"description\":\"Zur Verbesserung des Blutzuckerspiegels bei erwachsenen Patienten mit Diabetes mellitus Typ2:<br>\\n- anstelle von Empagliflozin, wenn die Blutzuckerkontrolle durch Diät, Bewegung und eine Behandlung mit Empagliflozin und Metformin oder mit Empagliflozin und einem Sulfonylharnstoff unzureichend ist.<br>\\n- anstelle von Linagliptin, wenn die Blutzuckerkontrolle durch Diät, Bewegung und eine Behandlung mit Linagliptin und Metformin oder mit Linagliptin und einem Sulfonylharnstoff unzureichend ist.<br>\\nAls Ersatz der freien Kombination von Empagliflozin und Linagliptin bei erwachsenen Patienten mit Diabetes mellitus Typ 2, welche bereits mit dieser Kombination behandelt werden.<br>\\n\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2018-03-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 10mg/5mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2018-03-01",
  "self_retention_pct": 10
}

See everything about linagliptin and empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.